The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Overactive Bladder
Interventions
OTHER

Botulinum toxin and cineMRI-UDS

The investigators will be testing the capability of cineMRI combined with simultaneous urodynamics in the context of OAB in this proposal and expect to reveal a new understanding of diseased lower urinary tract physiology. Participants will receive an injection of intravesical botulinum toxin after filling out validated questionnaires and receiving a pre-treatment cineMRI-UDS.

Trial Locations (1)

90211

RECRUITING

Cedars-Sinai Medical Center, Beverly Hills

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER